Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

About David Novis

This author hasn't entered any profile information yet.

Posts by David Novis

Results Confirm Idarucizumab’s Ability to Restore Clotting in Dabigatran Recipients

August 1, 2017 - Gene Emery (Reuters Health) - 0 Comment

The blood thinning effects of dabigatran (Pradaxa) can be quickly and reliably reversed by giving idarucizumab (Praxbind)…

Read More

Percutaneous Coronary Intervention Can Benefit Some at Age 90 and Older

July 25, 2017 - Anne Harding (Reuters Health) - 0 Comment

People in their nineties and older represent a tiny but growing fraction of patients who undergo percutaneous…

Read More

WHO Warns of Imminent Spread of Untreatable Gonorrhea

July 25, 2017 - Kate Kelland (Reuters) - 0 Comment

At least three people worldwide are infected with totally untreatable strains of gonorrhea which they are likely…

Read More

ACS-Designated Trauma Centers have Fewer Complications at Extremes of Age

July 18, 2017 - Will Boggs, MD (Reuters Health) - 0 Comment

Hospitals designated as trauma centers by the American College of Surgeons (ACS) have lower complication rates than…

Read More

Fewer Admissions for Heart Failure, but Blacks Still Fare Worse than Whites

July 18, 2017 - Will Boggs, MD (Reuters Health) - 1 Comment

Between 2002 and 2013, hospital admissions for heart failure fell by nearly a third in the U.S.,…

Read More

Vaccination May be Curbing Emergency Department Visits for Shingles

July 11, 2017 - Marilynn Larkin (Reuters Health) - 0 Comment

Emergency department (ED) visits for shingles fell in the past decade for people aged 60 and older…

Read More
  • 1
  • 2

Current Issue

ACEP Now: November 2025

Download PDF

Read More

Polls

Which topic would you like to see ACEP Now tackle?

View Results

Loading ... Loading ...
  • Polls Archive
Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603